Methods for assembly of high fidelity synthetic polynucleotides

• US 20070122817A1
• Filed: 02/28/2005
• Published: 05/31/2007
• Est. Priority Date: 02/28/2005
• Status: Abandoned Application

• Current Assignee: Codon Devices Incorporated
• Original Assignee: Codon Devices Incorporated
• Inventors: Church, George, Jacobson, Joseph, Baynes, Brian
• Application Number:
  US11/067,812
• Publication Number:
  US 20070122817A1
• Time in Patent Office: Days
• US Class Current: 435/6
• CPC Class Codes: C12Q 1/6806 Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay C12Q1/6804 takes precedence
• CPC Class Codes: C12Q 1/6844 Nucleic acid amplification reactions
• CPC Class Codes: C12Q 2521/501 Ligase
• CPC Class Codes: C12Q 2527/107 Temperature of melting, i.e. Tm
• CPC Class Codes: C12Q 2537/113 Heteroduplex formation

Abstract

Disclosed are methods of manufacturing synthetic DNAs, that is, DNAs made at least in significant part by chemical synthesis of polynucleotide polymers. Also provided are methods for assembling plural DNAs in the same pool by multiplexed assembly of synthetic oligonucleotides. In exemplary embodiments, the methods involve pre-amplification of one or more oligonucleotides using “universal” primers, reduction of the error rate in oligonucleotide and/or polynucleotide products, and sequence optimization and oligonucleotides design.

Claims

1. A method for assembling a long polynucleotide construct having a predefined sequence, comprising:

a) providing a pool of construction oligonucleotides;

b) conducting i), ii), or i) and ii) in either order or simultaneously;

i) amplifying said construction oligonucleotides; and

ii) subjecting said construction oligonucleotides to an error reduction process; and

c) exposing said pool of construction oligonucleotides to hybridization conditions and one or more of the following conditions;

(i) ligation, (ii) chain extension, or (iii) chain extension and ligation conditions, thereby forming a plurality of copies of at least one double stranded subassembly construct that is longer than said construction oligonucleotides;

d) conducting i), ii), or i) and ii) in either order or simultaneously;

i) amplifying said subassembly construct; and

ii) subjecting said subassembly construct to an error reduction process; and

e) incubating two or more subassembly constructs under hybridization conditions and one or more of the following conditions;

(i) ligation, (ii) chain extension, or (iii) chain extension and ligation conditions, thereby forming a plurality of copies of a long polynucleotide construct.

2. The method of claim 1, wherein the construction oligonucleotides are subjected to an error filtration process.

3. The method of claim 2, wherein the error filtration process comprises:

a) contacting the pool of construction oligonucleotides with a pool of selection oligonucleotides under hybridization conditions to form duplexes, wherein the selection oligonucleotides comprise sequences that are complementary to at least portions of the construction oligonucleotides, and wherein at least a portion of the duplexes are stable duplexes comprising a copy of a construction oligonucleotide and a copy of a selection oligonucleotide that do not contain a mismatch in the complementary region and a portion of the duplexes are unstable duplexes comprising a copy of a construction oligonucleotide and a copy of a selection oligonucleotide that contain one or more mismatches in the complementary region;

b) removing copies of the construction oligonucleotides that have formed unstable duplexes; and

c) denaturing the remaining duplexes thereby forming a purified pool of construction oligonucleotides; and

d) incubating the purified pool of construction oligonucleotides under hybridization conditions and at least one of the following conditions;

(i) ligation conditions, (ii) chain extension conditions, or (ii) chain extension and ligation conditions, thereby forming at least one subassembly construct.

4. The method of claim 3, wherein the selection oligonucleotides are immobilized on a solid support.

5. The method of claim 3, wherein the selection oligonucleotides comprise a biotin group at one terminus.

6. The method of claim 3, wherein copies of the construction oligonucleotides that have formed unstable duplexes are removed from the pool by controlling the stringency of hybridization or wash conditions, or both.

7. The method of claim 4, wherein the solid support is a column or beads.

8. The method of claim 3, further comprising amplifying the construction oligonucleotides prior to forming the subassembly construct.

9. The method of claim 3, further comprising repeating a)-c) at least one time prior to forming the subassembly construct.

10. The method of claim 1, wherein the construction oligonucleotides or the subassembly constructs are subjected to an error filtration process, comprising:

a) incubating the construction oligonucleotides or the subassembly construct with at least one agent that binds to a mismatch; and

b) removing copies of the construction oligonucleotides or the subassembly construct that bound to the agent.

11. The method of claim 10, wherein the agent is a mismatch binding protein.

12. The method of claim 11, wherein the mismatch binding protein is one or more of the following:

Fok I, T7 endonuclease, mutH, mutL, mutM, mutS, mutY, dam, thymidine DNA glycosylase (TDG), uracil DNA glycosylase, AlkA, MLH1, MSH2, MSH3, MSH6, Exonuclease I, T4 endonuclease V, Exonuclease V, RecJ exonuclease, FEN1 (RAD27), dnaQ (mutD), or polC (dnaE).

13. The method of claim 12, wherein the mismatch binding protein is mutS.

14. The method of claim 13, wherein the construction oligonucleotides or the subassembly construct are incubated with mutS in the presence of ATP.

15. The method of claim 14, wherein the ATP is present in an amount sufficient to increase the affinity of mutS for a duplex containing a mismatch to less than about 10 nanomolar.

16. The method of claim 12, wherein the mismatch binding protein is a DNA glycosylase.

17. The method of claim 12, wherein the mismatch binding protein is TDG.

18. The method of claim 10, further comprising amplification of the copies of the construction oligonucleotides or the subassembly construct that did not bind to the agent.

19. The method of claim 18, further comprising repeating a) and b) at least one time.

20. The method of claim 18, wherein copies of the construction oligonucleotides or the subassembly construct that bound to the agent are removed by gel filtration.

21. The method of claim 18, wherein the agent is immobilized on a substrate.

22. The method of claim 18, wherein the substrate is a column or beads.

23. The method of claim 18, further comprising cross-linking the agent to the construction oligonucleotides or the subassembly construct.

24. The method of claim 1, wherein the construction oligonucleotides or the subassembly construct are subjected to an error neutralization process, comprising:

a) incubating the construction oligonucleotides or the subassembly construct with an agent that binds to a mismatch; and

b) crosslinking the agent to the copies of the construction oligonucleotides or the subassembly construct that contain a mismatch; and

c) amplifying the construction oligonucleotides or the subassembly construct, wherein copies of the construction oligonucleotides or the subassembly construct that are crosslinked to the agent are not amplified exponentially and are diluted out.

25. The method of claim 1, wherein the subassembly construct is subjected to an error correction process.

26. The method of claim 25, wherein the error correction process comprises:

a) incubating a plurality of copies of the subassembly construct with an agent that cleaves the subassembly construct to create a double stranded break and remove the mismatch;

b) melting and reannealing the plurality of copies of the subassembly construct;

c) incubating the plurality of copies of the subassembly construct under hybridization and chain extension conditions, wherein strands of the subassembly construct that were cleaved by the agent can hybridize to overlapping, complementary strands and serve as primers for chain extension.

27. The method of claim 26, wherein the agent is a fusion protein comprising a mismatch binding protein, or a functional fragment thereof, and a nuclease, or a functional fragment thereof.

28. The method of claim 26, wherein the agent is Fok I, T7 endonuclease I or T4 endonuclease.

29. The method of claim 25, wherein the error correction process comprises:

a) contacting a plurality of copies of the subassembly construct with a methylation agent;

b) contacting the plurality of copies of the subassembly construct with a site-specific demethylation agent;

c) denaturing the plurality of copies of the subassembly construct;

d) renaturing the plurality of copies of the subassembly construct thereby forming a plurality of copies of the double stranded subassembly construct at least a portion of which comprise at least one hemimethylated region; and

e) contacting the plurality of copies of the subassembly construct with a mismatch repair system.

30. The method of claim 29, wherein the site-specific demethylation agent is a fusion protein comprising a mismatch binding protein, or a functional fragment thereof, and a demethylase, or a functional fragment thereof.

31. The method of claim 25, wherein the error correction process comprises:

a) incubating a plurality of copies of the subassembly construct with an agent that cleaves the subassembly construct to create a double stranded break and remove the mismatch;

b) contacting the plurality of copies of the subassembly construct with an agent that promotes formation of Holliday junctions;

c) incubating the plurality of copies of the subassembly construct under conditions that promote chain extension; and

d) contacting the plurality of copies of the subassembly construct with an agent that promotes resolution of the Holliday junctions.

32. The method of claim 1, further comprising subjecting the long polynucleotide construct to an error reduction process.

33. The method of claim 32, wherein the error reduction process comprises:

a) contacting the plurality of copies of the long polynucleotide construct with an agent that causes site-specific double stranded breaks and cohesive ends thereby producing fragments;

b) contacting the fragments with an agent that binds to a mismatch;

c) removing fragments that bound to the agent; and

d) incubating the fragments under conditions that promote hybridization and ligation of the cohesive ends, thereby reforming the long polynucleotide construct.

34. The method of claim 33, wherein the agent that causes site-specific double stranded breaks is FokI, T7 endonuclease I, or T4 endonuclease.

35. The method of claim 32, wherein the error reduction process comprises:

a) contacting the plurality of copies of the long polynucleotide construct with an agent that causes non-specific single-stranded breaks;

b) contacting the plurality of copies of the long polynucleotide construct with an agent that promotes formation of Holliday junctions;

c) incubating the plurality of copies of the long polynucleotide construct under conditions that promote chain extension; and

d) contacting the plurality of copies of the long polynucleotide construct with an agent that promotes resolution of the Holliday junctions

36. The method of claim 32, wherein the error reduction process comprises:

a) contacting the plurality of copies of the long polynucleotide construct with an agent that cause non-specific double stranded breaks thereby forming double stranded fragments;

b) denaturing the fragments thereby forming single stranded fragments;

c) incubating the fragments under conditions which promote hybridization between complementary overlapping single stranded fragments;

d) contacting the fragments with an agent that binds to a mismatch;

e) removing fragments that bound to the agent; and

f) incubating fragments under hybridization conditions and at least one of the following conditions;

(i) ligation, (ii) chain extension, or (iii) chain extension and ligation conditions, to reassemble the long polynucleotide construct.

37. The method of claim 1, wherein said pool forms a plurality of double stranded subassembly constructs.

38. The method of claim 1, wherein the two or more subassembly constructs are assembled in separate reactions.

39. The method of claim 1, wherein the two or more subassembly constructs are assembled in the same reaction.

40. The method of claim 1, wherein a plurality of subassembly constructs are incubated under hybridization conditions and at least one of the following conditions:

(i) ligation conditions, (ii) chain extension conditions, (iii) chain extension and ligation conditions, thereby forming a plurality of long polynucleotide constructs.

41. The method of claim 1, further comprising a round of denaturation and renaturation prior to conducting an error reduction process.

42. The method of claim 1, wherein the construction oligonucleotides are from about 20 to about 150 nucleotides in length.

43. The method of claim 1, wherein the subassembly construct is at least about 200 to about 750 nucleotides in length.

44. The method of claim 1, wherein the subassembly construct is at least about 5 times as long as the construction oligonucleotides.

45. The method of claim 1, wherein the polynucleotide construct is at least about 5 times as long as the subassembly construct.

46. The method of claim 1, wherein the polynucleotide construct is at least about 1 kilobase in length.

47. The method of claim 46, wherein the polynucleotide construct is at least about 10 kilobases in length.

48. The method of claim 47, wherein the polynucleotide construct is at least about 100 kilobases in length.

49. The method of claim 1, wherein less than about 99% of the copies of the subassembly or polynucleotide constructs have a sequence error.

50. The method of claim 49, wherein less than about 95% of the copies of the subassembly or polynucleotide constructs have a sequence error.

51. The method of claim 50, wherein less than about 90% of the copies of the subassembly or polynucleotide constructs have a sequence error.

52. The method of claim 51, wherein less than about 50% of the copies of the subassembly or polynucleotide constructs have a sequence error.

53. The method of claim 1, wherein said oligonucleotides are synthesized on a solid support.

54. The method of claim 53, wherein the oligonucleotides are attached to the solid support by a cleavable linker.

55. The method of claim 54, wherein the linker is a chemically cleavable linker, a thermally cleavable linker, an enzymatically cleavable linker, or a photocleavable linker.

56. The method of claim 53, wherein the synthesis uses light triggered reactions at discrete location on said support.

57. The method of claim 56, wherein the light is directed to discrete locations using masks.

58. The method of claim 57, wherein the light is directed to discrete locations using light directing maskless optics.

59. The method of claim 53, wherein the oligonucleotides are severed from the solid support prior to amplification.

60. The method of claim 1, wherein said oligonucleotides comprise at least one pair of primer hybridization sites flanking at least a portion of said oligonucleotides and common to at least a subset of said oligonucleotides.

61. The method of claim 60, wherein all of the oligonucleotides comprise at least one pair of primer hybridization sites in common.

62. The method of claim 60, wherein said oligonucleotides comprise cleavage sites between at least a portion of the primer hybridization sites and the oligonucleotides.

63. The method of claim 62, wherein the cleavage site is a restriction endonuclease site.

64. The method of claim 63, wherein the restriction endonuclease is a type IIS endonuclease.

65. The method of claim 1, wherein said subassembly constructs comprise at least one pair of primer hybridization sites flanking at least a portion of said subassembly constructs and common to at least a subset of said subassembly constructs.

66. The method of claim 65, wherein the subassembly constructs comprise a cleavage site between at least one of the primer hybridization sites and the subassembly constructs.

67. The method of claim 1, wherein the amplification of the construction oligonucleotides or the subassembly constructs uses at least one primer containing at least one uracil residue.

68. The method of claim 67, wherein the uracil residue is located at the junction between the primer hybridization site and the construction oligonucleotides or the subassembly constructs.

69. The method of claim 67, wherein the primer hybridization site is removed using uracil DNA glycosylase and an AP endonuclease.

70. The method of claim 1, wherein at least two subassembly constructs are formed in the same reaction mixture.

71. The method of claim 70, wherein at least four subassembly constructs are formed in the same reaction mixture.

72. The method of claim 71, wherein at least ten subassembly constructs are formed in the same reaction mixture.

73. The method of claim 1, wherein at least two polynucleotide constructs are formed in the same reaction mixture.

74. The method of claim 73, wherein at least four polynucleotide constructs are formed in the same reaction mixture.

75. The method of claim 74, wherein at least ten polynucleotide constructs are formed in the same reaction mixture.

76. A method for preparing a long polynucleotide construct having a predefined sequence, comprising:

a) providing a pool of input oligonucleotides under hybridization conditions and at least one of the following conditions;

(i) ligation conditions, (ii) chain extension conditions, or (iii) chain extension and ligation conditions, wherein said pool comprises a plurality of overlapping sequences, and wherein said pool forms at least one product polynucleotide that is longer than said oligonucleotides;

b) conducting i) and ii) in either order or simultaneously;

i) amplifying said product polynucleotides; and

ii) subjecting said product polynucleotides to an error reduction process; and

c) repeating steps a) and b) at least two times, wherein said product polynucleotides constitute the input oligonucleotides in the next cycle.

77. The method of claim 76, wherein the pool of input oligonucleotides comprises positive and negative strands that are complementary in the overlapping regions.

78. The method of claim 76, wherein the pool of input oligonucleotides is amplified prior to forming a polynucleotide product.

79. The method of claim 76, wherein the pool of input oligonucleotides is subjected to an error reduction process prior to forming a polynucleotide product.

80. The method of claim 79, wherein the error reduction process is error filtration using a pool of selection oligonucleotides.

81-162. -162. (canceled)